FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Medical Devices

CDRH Seeks Input on Cybersecurity Servicing Practices

CDRH releases for comment a discussion paper on cybersecurity practices associated with medical device servicing.

Medical Devices

Lawmakers Urge FDA to Prioritize T Cell Covid Tests

Several Republican members of Congress urge FDA to prioritize tests measuring the presence of T cell-mediated immunity to Covid-19.

Human Drugs

Woodcock, 2 Others Must Go Over Aducanumab: Public Citizen

Public Citizen says FDA acting commissioner Janet Woodcock and two other top agency officials need to resign or be fired for their roles in the accele...

Medical Devices

Class 1 Recall of Alaris Pump Bezels

FDA classifies as Class 1 a recall of the Alaris Infusion Pump Module Model 8100 Bezel, purchased or installed by Infusion Pump Repair.

Human Drugs

No Change in Risk/Benefit Analysis: Cavazzoni

CDER director Patrizia Cavazzoni says drug companies and FDA still have progress to make in ensuring diversity and health equity in clinical trials.

Human Drugs

Industry MIDD Paired Meeting Program Benefits Cited

Industry representatives say the Model-Informed Drug Development paired meeting program started under PDUFA 6 in 2018 should be continued and expanded...

Human Drugs

FDA Releases 15 Million Doses of Janssen Vaccine

FDA authorizes another vaccine drug substance batch (15 million doses) that was manufactured at troubled Emergent BioSolutions Baltimore facility for ...

Human Drugs

FDA Grievously and Horribly Broken: Professor

University of California San Francisco associate professor of medicine Vinay Prasad says recent FDA actions demonstrate how broken the agency is and h...

Human Drugs

Safety Alert on Fumes from Hand Sanitizers

FDA issues a drug safety alert on alcohol-based hand sanitizers, warning that vapors may cause symptoms such as headache, nausea, and dizziness.

Human Drugs

Biogen Scraps Investigational Alzheimers Drug

Biogen halts development of gosuranemab, an investigational anti-tau antibody that was being evaluated as a potential treatment for Alzheimers disease...